Terms: = Pancreatic cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566
86 results:
1. Construction and validation of a nomogram for cancer specific survival of postoperative pancreatic cancer based on the SEER and China database.
Peng W; Yu X; Yang R; Nie S; Jian X; Zeng P
BMC Gastroenterol; 2024 Mar; 24(1):104. PubMed ID: 38481160
[TBL] [Abstract] [Full Text] [Related]
2. Early experience with robotic pancreatoduodenectomy versus open pancreatoduodenectomy: nationwide propensity-score-matched analysis.
de Graaf N; Zwart MJW; van Hilst J; van den Broek B; Bonsing BA; Busch OR; Coene PLO; Daams F; van Dieren S; van Eijck CHJ; Festen S; de Hingh IHJT; Lips DJ; Luyer MDP; Mieog JSD; van Santvoort HC; van der Schelling GP; Stommel MWJ; de Wilde RF; Molenaar IQ; Groot Koerkamp B; Besselink MG
Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38415878
[TBL] [Abstract] [Full Text] [Related]
3. Trends in access to minimally invasive pancreaticoduodenectomy for pancreatic cancers.
Seldomridge AN; Rasic G; Papageorge MV; Ng SC; de Geus SWL; Woods AP; McAneny D; Tseng JF; Sachs TE
HPB (Oxford); 2024 Mar; 26(3):333-343. PubMed ID: 38087704
[TBL] [Abstract] [Full Text] [Related]
4. Smoking Cessation and pancreatic cancer Risk in Individuals With Prediabetes and Diabetes: A Nationwide Cohort Study.
Park JH; Hong JY; Shen JJ; Han K; Park YS; Park JO
J Natl Compr Canc Netw; 2023 Nov; 21(11):1149-1155.e3. PubMed ID: 37935099
[TBL] [Abstract] [Full Text] [Related]
5. Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.
Lei Z; Ma W; Si A; Zhang Y; Yang F; Yu Q; Tang H; Xiao Q; Zhou J; Wang K; Tang Y; Han T; Yin G; Chen J; Liu X; Zhao H; Yu D; Luo T; Wang Q; Yan M; Mao X; Li J; Wang K; Li J; Zeng Y; Ding D; Chen T; Wu X; Xia Y; Wang K; Guo W; Zhu G; Gao S; Hüser N; Lau WY; Song T; Cheng S; Shen F; Cheng Z
Aliment Pharmacol Ther; 2023 Sep; 58(6):611-622. PubMed ID: 37349908
[TBL] [Abstract] [Full Text] [Related]
6. Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic pancreatic Adenocarcinoma.
Spitzer HV; Kemp Bohan PM; Carpenter EL; Adams AM; Chang SC; Grunkemeier G; Vreeland TJ; Tzeng CD; Katz MHG; Nelson DW
Ann Surg Oncol; 2023 Oct; 30(11):6662-6670. PubMed ID: 37330447
[TBL] [Abstract] [Full Text] [Related]
7. The Diagnostic and Prognostic Value of miR-155 in cancers: An Updated Meta-analysis.
Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
[TBL] [Abstract] [Full Text] [Related]
8. The implications of fragmented practice in hepatopancreatic surgery.
Moazzam Z; Lima HA; Endo Y; Alaimo L; Ejaz A; Dillhoff M; Cloyd J; Pawlik TM
Surgery; 2023 Jun; 173(6):1391-1397. PubMed ID: 36907781
[TBL] [Abstract] [Full Text] [Related]
9. Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study.
Fujitani H; Eguchi H; Kochi Y; Arai T; Muramatsu M; Okazaki Y
Eur J Cancer Prev; 2023 May; 32(3):286-297. PubMed ID: 36896836
[TBL] [Abstract] [Full Text] [Related]
10. Nationwide validation of the ISGPS risk classification for postoperative pancreatic fistula after pancreatoduodenectomy: "Less is more".
Suurmeijer JA; Emmen AM; Bonsing BA; Busch OR; Daams F; van Eijck CH; van Dieren S; de Hingh IH; Mackay TM; Mieog JS; Molenaar IQ; Stommel MW; de Meijer VE; van Santvoort HC; Groot Koerkamp B; Besselink MG;
Surgery; 2023 May; 173(5):1248-1253. PubMed ID: 36858874
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy and Safety of Radiofrequency Ablation Plus Stent Versus Stent-alone Treatments for Malignant Biliary Strictures: A Systematic Review and Meta-analysis.
Khizar H; Hu Y; Wu Y; Ali K; Iqbal J; Zulqarnain M; Yang J
J Clin Gastroenterol; 2023 Apr; 57(4):335-345. PubMed ID: 36628465
[TBL] [Abstract] [Full Text] [Related]
12. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
[TBL] [Abstract] [Full Text] [Related]
13. Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery.
Famularo S; Donadon M; Cipriani F; Fazio F; Ardito F; Iaria M; Perri P; Conci S; Dominioni T; Lai Q; La Barba G; Patauner S; Molfino S; Germani P; Zimmitti G; Pinotti E; Zanello M; Fumagalli L; Ferrari C; Romano M; Delvecchio A; Valsecchi MG; Antonucci A; Piscaglia F; Farinati F; Kawaguchi Y; Hasegawa K; Memeo R; Zanus G; Griseri G; Chiarelli M; Jovine E; Zago M; Abu Hilal M; Tarchi P; Baiocchi GL; Frena A; Ercolani G; Rossi M; Maestri M; Ruzzenente A; Grazi GL; Dalla Valle R; Romano F; Giuliante F; Ferrero A; Aldrighetti L; Bernasconi DP; Torzilli G;
JAMA Surg; 2023 Feb; 158(2):192-202. PubMed ID: 36576813
[TBL] [Abstract] [Full Text] [Related]
14. Sarcopenia is an Independent Prognostic Factor in Patients With pancreatic cancer - a Meta-analysis.
Thormann M; Hinnerichs M; Barajas Ordonez F; Saalfeld S; Perrakis A; Croner R; Omari J; Pech M; Zamsheva M; Meyer HJ; Wienke A; Surov A
Acad Radiol; 2023 Aug; 30(8):1552-1561. PubMed ID: 36564257
[TBL] [Abstract] [Full Text] [Related]
15. A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma.
Xu K; Xia P; Liu P; Zhang X
Sci Rep; 2022 Dec; 12(1):20781. PubMed ID: 36456877
[TBL] [Abstract] [Full Text] [Related]
16. Tranexamic acid and blood loss in pancreaticoduodenectomy: TAC-PD randomized clinical trial.
Ishii K; Yokoyama Y; Yonekawa Y; Hayashi D; Kinoshita F; Kuwatsuka Y; Okuno M; Natsume S; Minami T; Sugawara G; Seita K; Sato F; Aoba T; Shimizu Y; Kurumiya Y; Maeda A; Yamaguchi R; Hiramatsu K; Ebata T
Br J Surg; 2023 Jan; 110(2):159-165. PubMed ID: 36379883
[TBL] [Abstract] [Full Text] [Related]
17. Minimally invasive versus open hepatectomy for the resection of colorectal liver metastases: a systematic review and meta-analysis.
Ozair A; Collings A; Adams AM; Dirks R; Kushner BS; Sucandy I; Morrell D; Abou-Setta AM; Vreeland T; Whiteside J; Cloyd JM; Ansari MT; Cleary SP; Ceppa E; Richardson W; Alseidi A; Awad Z; Ayloo S; Buell JF; Orthopoulos G; Sbayi S; Wakabayashi G; Slater BJ; Pryor A; Jeyarajah DR
Surg Endosc; 2022 Nov; 36(11):7915-7937. PubMed ID: 36138246
[TBL] [Abstract] [Full Text] [Related]
18. The relationships between antihypertensive medications and the overall survival of patients with pancreatic cancer: a systematic review and meta-analysis.
Jiang W; He R; Lu Y; Zhou W
Expert Rev Gastroenterol Hepatol; 2022 Jun; 16(6):547-553. PubMed ID: 35686669
[TBL] [Abstract] [Full Text] [Related]
19. Impact of hemolysis on multi-OMIC pancreatic biomarker discovery to derisk biomarker development in precision medicine studies.
Searfoss R; Shah P; Ofori-Mensa K; Bussberg V; Tolstikov V; Greenwood B; Li H; Richardson K; Miller GM; DeCicco C; Granger E; Rodrigues LO; Grund EM; Moser AJ; Sarangarajan R; Narain NR; Kiebish MA
Sci Rep; 2022 Jan; 12(1):1186. PubMed ID: 35075163
[TBL] [Abstract] [Full Text] [Related]
20. Does minimally invasive liver resection improve long-term survival compared to open resection for hepatocellular carcinoma? A systematic review and meta-analysis.
Kamarajah SK; Gujjuri RR; Hilal MA; Manas DM; White SA
Scand J Surg; 2022; 111(1):14574969211042455. PubMed ID: 34605328
[TBL] [Abstract] [Full Text] [Related]
[Next]
